Frank Rimerman Advisors LLC Increases Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Frank Rimerman Advisors LLC increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 7.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 408 shares of the medical instruments supplier’s stock after acquiring an additional 28 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Mettler-Toledo International were worth $499,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Farther Finance Advisors LLC lifted its stake in Mettler-Toledo International by 14.3% in the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 8 shares during the period. Huntington National Bank lifted its position in Mettler-Toledo International by 20.0% during the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares during the period. Townsquare Capital LLC lifted its position in Mettler-Toledo International by 2.0% during the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after buying an additional 9 shares during the period. M3 Advisory Group LLC lifted its position in Mettler-Toledo International by 5.8% during the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after buying an additional 9 shares during the period. Finally, Apollon Wealth Management LLC lifted its position in Mettler-Toledo International by 2.5% during the fourth quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock valued at $451,000 after buying an additional 9 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the company. Citigroup lowered their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Evercore ISI lifted their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,380.50.

Insider Buying and Selling

In related news, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,231.32 on Monday. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The stock has a 50-day moving average of $1,295.03 and a 200 day moving average of $1,316.72. The company has a market capitalization of $25.75 billion, a price-to-earnings ratio of 30.38, a PEG ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.